A new article in the Wall Street Journal talks about the next sector to be hit by "Bonus hungry CEO's"...Biotechnology. After the banking, auto-industry, and hedge-fund sectors fell to much public scrutiny for its bordering-on-insane executive bonuses, investors are looking at some executive payouts for Biotechnology, and seeing the same trends. The WSJ article even talks about some executive payouts for small pharmaceutical companies that representeded over 10% of the companies market-cap. Shouldnt these companies be spending the vast majority of their money on R&D, and less on executive bonuses and marketing? Check out the full article, and tell us what you think. Do these executives deserve these payouts, or is it a load of BS? [Link]
Wednesday, July 1, 2009
Scientists and Investors Clash with C.E.O.'s
A new article in the Wall Street Journal talks about the next sector to be hit by "Bonus hungry CEO's"...Biotechnology. After the banking, auto-industry, and hedge-fund sectors fell to much public scrutiny for its bordering-on-insane executive bonuses, investors are looking at some executive payouts for Biotechnology, and seeing the same trends. The WSJ article even talks about some executive payouts for small pharmaceutical companies that representeded over 10% of the companies market-cap. Shouldnt these companies be spending the vast majority of their money on R&D, and less on executive bonuses and marketing? Check out the full article, and tell us what you think. Do these executives deserve these payouts, or is it a load of BS? [Link]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment